Figure 2.

Schematic illustration of how a precision therapy could be applied in epilepsy. Treatment of epilepsy remains largely empirical and rather than the present trial and error approach (A), genetic testing and preclinical in vitro and in vivo models may enable healthcare providers to select a more targeted treatment approach (B).